Live Breaking News & Updates on Novosibirsk Based Vector State Research Center|Page 1

Stay updated with breaking news from Novosibirsk based vector state research center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Output of Russian Covid-19 vaccine EpiVacCorona to top 3 mln doses in 2021

Output of Russian Covid-19 vaccine EpiVacCorona to top 3 mln doses in 2021
interfax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from interfax.com Daily Mail and Mail on Sunday newspapers.

Rinat Maksyutov , Vector Center , Vector State Research Center , Novosibirsk Based Vector State Research Center , State Duma , திசையன் மையம் , திசையன் நிலை ஆராய்ச்சி மையம் , நிலை டுமா ,

Russia's Chumakov Center plans to start Phase 3 trials of CoviVac vaccine in several weeks


25 May 2021 13:30
Russia s Chumakov Center plans to start Phase 3 trials of CoviVac vaccine in several weeks - general director
MOSCOW. May 25 (Interfax) - Phase 3 clinical trials of the Covid-19 whole-virion vaccine CoviVac may begin in a couple of weeks, according to Aidar Ishmukhametov, general director of the Russian Academy of Sciences Chumakov Federal Center for Research and Development of Immune-and-Biological Products, the vaccine s developer.
It is up to the Health Ministry to make this decision. We submitted [documents to start Phase 3 trials of the CoviVac vaccine], we were asked additional questions, as it usually happens, and we answered them. We are now awaiting its decision. I think that we will start Phase 3 trials of CoviVac in a week or two, Ishmukhametov said in an interview published in the Izvestia newspaper on Tuesday. ....

Stavropol Skiy Kray , Aidar Ishmukhametov , Russian Academy Of Science Chumakov Federal Center , Development Of Products , Chumakov Center Covivac , Gamaleya National Research Center , Russia Chumakov Center , Health Ministry , Rospotrebnadzor Vector State Research Center , Chumakov Center , Russian Academy , Science Chumakov Federal Center , Immune And Biological Products , Sputnik Light , Novosibirsk Based Vector State Research Center , வளர்ச்சி ஆஃப் ப்ராடக்ட்ஸ் , ஆரோக்கியம் அமைச்சகம் , ரஷ்ய கலைக்கழகம் , நோய் எதிர்ப்பு சக்தி மற்றும் உயிரியல் ப்ராடக்ட்ஸ் , ஸ்பட்நிக் ஒளி ,

100% of volunteers develop COVID-19 antibodies from EpiVacCorona vaccine - aysor.am


100% of volunteers develop COVID-19 antibodies from EpiVacCorona vaccine
 All volunteers aged from 18 to 60, participating in the EpiVacCorona vaccine post-registration studies, have developed antibodies to COVID-19, Head of the Vector State Research Center of Virology and Biotechnology’s Zoonotic Infections and Influenza Department Alexander Ryzhikov told TV Channel One.
The first group of volunteers [aged from 18 to 60] showed 100% immunological efficacy, that is all vaccinated healthy individuals under the age of 60 had generated antibodies [to COVID-19], he stated.
Ryzhikov noted that the immunological efficacy in the volunteers aged over 60 was slightly lower and amounted to 94%. It s an excellent result for this age, the expert concluded. ....

Bryanskaya Oblast , Vladimir Putin , Head Of The Vector State Research Center , Influenza Department Alexander Ryzhikov , Vector State Research Center , Russia Health Ministry , Health Ministry , Zoonotic Infections , Novosibirsk Based Vector State Research Center , Russian President Vladimir Putin , Armenian News , Recent News From Armenia , Republic Of Armenia , Nagorno Karabakh , Armenian Genocide , Armenian Diaspora , Armenian Community , Armenian American , American Armenian , விளாடிமிர் புட்டின் , தலை ஆஃப் தி திசையன் நிலை ஆராய்ச்சி மையம் , திசையன் நிலை ஆராய்ச்சி மையம் , ரஷ்யா ஆரோக்கியம் அமைச்சகம் , ஆரோக்கியம் அமைச்சகம் , ரஷ்ய ப்ரெஸிடெஂட் விளாடிமிர் புட்டின் , ஆர்மீனியன் செய்தி ,

Russia sends EpiVacCorona vaccine trial results to foreign scientific journals


Russia sends EpiVacCorona vaccine trial results to foreign scientific journals
The Russian sanitary watchdog emphasized that it was not appropriate to publish the results in the Russian-language scientific journals until the international publications were released
© Maxim Slutsky/TASS
MOSCOW, February 10. /TASS/. Russia’s Vector State Research Center of Virology and Biotechnology submitted the results of the Phase One and Two clinical trials of the EpiVacCorona vaccine to foreign scientific journals, the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing told reporters on Wednesday.
The Vector State Research Center of Virology and Biotechnology has sent the results of the Phase One and Two vaccine clinical trials to foreign peer-reviewed scientific journals. The publication is expected in the near future, the sanitary watchdog’s press service stated. ....

Vladimir Putin , Vector State Research Center , Service For Surveillance On Consumer Rights Protection , Russia Health Ministry , Health Ministry , Russia Vector State Research Center , Phase One , Federal Service , Consumer Rights Protection , Human Wellbeing , Novosibirsk Based Vector State Research Center , Russian President Vladimir Putin , விளாடிமிர் புட்டின் , திசையன் நிலை ஆராய்ச்சி மையம் , சேவை க்கு கண்காணிப்பு ஆன் நுகர்வோர் உரிமைகள் ப்ரொடெக்ஶந் , ரஷ்யா ஆரோக்கியம் அமைச்சகம் , ஆரோக்கியம் அமைச்சகம் , ரஷ்யா திசையன் நிலை ஆராய்ச்சி மையம் , கட்டம் ஒன்று , கூட்டாட்சியின் சேவை , நுகர்வோர் உரிமைகள் ப்ரொடெக்ஶந் , மனிதன் நல்வாழ்வு , ரஷ்ய ப்ரெஸிடெஂட் விளாடிமிர் புட்டின் ,